This Insider Spent $100,000: Is a Turnaround Imminent?
When an insider doubles down on a falling stock, investors sit up and take notice. This article breaks down what it c...
Analyze when to tilt toward stocks or bonds in retirement. A practical guide to selecting the right index mix for your goals.
22,201 articlesWhen an insider doubles down on a falling stock, investors sit up and take notice. This article breaks down what it c...
Circle Internet Group’s stock surged about 20% after two U.S. senators announced a bipartisan compromise on stablecoi...
Gas costs have ticked higher, but household responses split by income and city. The investing world watches how these...
Tesla is recalling more than 218,000 cars and SUVs due to a rearview camera delay that could impair reversing visibil...
A data-focused small-cap could ride the wave of real-time sports analytics and licensing revenue. This article breaks...
Barclays lifts Atlassian price target to $112, signaling growing confidence in the company’s ARR trajectory and enter...
Magnolia (MGY) is delivering a pivotal Q1 2026 performance that tests the durability of its business model. This arti...
A breakthrough approval can move a biotech stock in dramatic ways. This guide breaks down how to assess the upside, m...
NVIDIA led the AI chip boom, but growing competition and supply forces may erode its edge. This guide breaks down the...
Learn how xometry (xmtr) 2026 earnings shape the investment case. We break down the numbers, strategy, and risks, wit...
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
XRP sits around $1.40 as institutions quietly expand tokenized-asset settlements on public rails, even as on-chain ac...